Key points are not available for this paper at this time.
In summary, we developed a safe FEID anti-tumor nanoplatform through a simple self-assembly process. This platform demonstrates the potential for controlled drug release and efficient combination therapy.
Cao et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: